HPV Biology
Tools for HPV16, HPV18, E6/E7, viral oncogene expression and host-cell change.
Cervical Tumor Research · HPV16 · HPV18 · E6/E7 · p16 · Ki-67
Cervical Cancer Research Products
Explore research-use products for cervical tumor biology, HPV-driven carcinogenesis, cervical squamous cell carcinoma, cervical adenocarcinoma, CIN progression, transformation-zone biology, HPV16 and HPV18 studies, E6/E7 oncogene pathways, p53/RB disruption, p16INK4a, Ki-67, PD-L1, VEGF, immune escape, angiogenesis, invasion, metastasis, cervical tumor models and functional assay workflows.
Products and content are intended for research and educational use only.
They are not presented as diagnostic, therapeutic or medical-use products.
HPV16
E6/E7
p16
Ki-67
PD-L1
Research Categories
Cervical cancer research product categories
Build cervical tumor research workflows using antibodies, ELISA kits, recombinant proteins, molecular biology tools, cell culture reagents and functional assay systems.
01
Antibodies
Cervical Tumor Antibodies
Primary antibodies for HPV E6/E7, p16INK4a, Ki-67, p53, RB, cytokeratins, PD-L1, VEGF, MMPs, EMT markers and cervical tumor microenvironment studies.
View antibodies
02
ELISA
ELISA Kits & Quantitative Assays
Kits and assays for cytokines, angiogenesis markers, immune checkpoints, inflammatory mediators, VEGF, MMPs and cervical tumor biology workflows.
View ELISA kits
03
Proteins
Recombinant Proteins & Controls
Recombinant proteins, assay standards, controls and calibrators for HPV-related pathway studies, antibody validation and biomarker assay development.
View proteins
04
Molecular
DNA, RNA & qPCR Tools
Molecular tools for HPV DNA/RNA workflows, E6/E7 expression, p53/RB pathway genes, EMT, hypoxia, immune markers and cervical cancer subtype profiling.
View molecular tools
05
Cells
Cell Culture & Model Tools
Media, supplements, matrices, transfection reagents and model-system tools for HPV-positive and HPV-negative cervical cancer cells, spheroids and resistance models.
View culture tools
06
Assays
Viability, Apoptosis & Invasion Assays
ATP, cytotoxicity, apoptosis, proliferation, migration, invasion, DNA damage, oxidative stress, angiogenesis and immune-response assay systems.
View assay tools
Biomarker Constellation
Important cervical cancer research biomarkers
Cervical cancer research often studies viral oncogene activity, epithelial transformation, proliferation, immune suppression, angiogenesis and invasion.
E6
HPV oncogene research marker
E6 is studied because high-risk HPV E6 disrupts tumor-suppressor biology, especially p53-associated pathways.
E7
Cell-cycle pathway marker
E7 is studied because it disrupts RB-family cell-cycle control, supporting abnormal proliferation.
p16
HPV-driven dysregulation marker
p16INK4a is widely studied in HPV-associated cervical lesions and cervical tumor biology.
PD-L1
Immune microenvironment marker
PD-L1 is studied in cervical tumor immune escape, checkpoint biology and treatment-response research.
Cervical Tumor Markers
HPV16
E6
E7
p16
Ki-67
PD-L1
Workflow Selector
Select products by cervical cancer workflow
Choose a workflow and get product groups matched to cervical tumor research needs.
IHC / Tissue Research
Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, p16INK4a, Ki-67, p53, RB, cytokeratins, PD-L1, VEGF, MMPs and cervical tumor tissue controls.
Browse tissue research products
Applications
Applications in cervical cancer research
Use cervical tumor research products across HPV biology, dysplasia progression, tissue profiling, molecular pathway analysis, immune studies and drug-response models.
HPV-driven carcinogenesis
Study HPV16, HPV18, E6/E7 expression, p53/RB disruption and viral persistence.
CIN progression
Analyze low-grade and high-grade cervical lesions, p16, Ki-67 and epithelial transformation.
Squamous cell carcinoma
Profile squamous differentiation, cytokeratins, proliferation, invasion and immune markers.
Adenocarcinoma research
Study glandular differentiation, cervical adenocarcinoma markers and HPV-associated pathways.
Immune microenvironment
Measure PD-L1, cytokines, T-cell markers, macrophage markers and immune escape pathways.
Drug-response studies
Measure viability, apoptosis, DNA damage, cytotoxicity, radiosensitivity and invasion response.
Product Match
Target
Subtype
Sample
Assay
Controls
Selection Guide
How to choose cervical cancer research products
Product selection should match the biological target, cervical cancer subtype, sample type, assay format and validation requirements.
Define the target biology
Examples: HPV E6/E7, p16/Ki-67, immune checkpoints, angiogenesis, EMT, invasion or DNA damage.
Match the disease context
Review whether the product supports CIN, squamous carcinoma, adenocarcinoma, HPV-positive or HPV-negative model research.
Check assay compatibility
Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.
Use controls and standards
Include positive controls, negative controls, calibrators, reference lysates, recombinant standards and reproducibility checks.
Browse cervical cancer research products
Explore research-use tools for HPV biology, E6/E7 pathways, p16/Ki-67 profiling, cervical dysplasia progression, immune microenvironment studies, angiogenesis, invasion, cervical tumor models and experimental drug-response workflows.
FAQ
FAQ: Cervical Cancer Research Products
Clear answers to common product-selection and cervical tumor workflow questions.
What are cervical cancer research products?
Cervical cancer research products are laboratory-use reagents and assay tools used to study HPV-driven cervical tumor biology, E6/E7 oncogene pathways, dysplasia progression, biomarkers, cell models, immune escape, invasion and drug response.
Which biomarkers are commonly studied in cervical cancer research?
Frequently studied markers include HPV16, HPV18, E6, E7, p16INK4a, Ki-67, p53, RB, PD-L1, VEGF, MMPs, cytokeratins, EMT markers and inflammatory cytokines.
Which products are useful for cervical tumor tissue studies?
Tissue-based studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, p16, Ki-67, p53, PD-L1, VEGF and epithelial differentiation markers.
Are these products for diagnostic or therapeutic use?
No. Products described on this page are presented for research use only unless an individual product page clearly states otherwise.
References
Scientific References
Authoritative sources supporting cervical cancer biology, biomarkers and research context.
- National Cancer Institute. Cervical cancer causes, risk factors and HPV prevention context.
- Review literature on HPV-driven cervical cancer molecular development.
- Research literature on HPV E6/E7, p53 and RB pathway disruption.
- Review literature on p16/Ki-67 dual staining and cervical lesion research.
- Research literature on cervical tumor microenvironment, PD-L1, angiogenesis and invasion biology.